55.94 F
December 8, 2023
Image default

U.S. delays decision on COVID vaccine for children under 5 by at least 2 months

Published by

By Ankur Banerjee and Michael Erman (Reuters) – A U.S. decision on Pfizer and BioNTech’s COVID-19 vaccine for children 6 months through 4 years of age has been postponed for at least two months after the Food and Drug Administration said it needed more data. The FDA had planned to make a decision on the vaccine based on early trial data because of what it had called a great public health need due to the surge in infections caused by the Omicron variant of the coronavirus. The decision was slated for next week with a rollout starting as soon as Feb. 21. On Friday, the agency said it had reviewe…

Read More

Related posts

Biden COVID-19 vaccine mandate for private-sector workers to begin Jan. 4


Surge in US jobless claims underscores need for stimulus


Biden nominates first female deputy defense secretary


Johnson hails trade pact: Many said deal this year was ‘impossible’


Trump says he won’t attend Biden inauguration. Biden says: Good.


Biden says believes ‘we will be the winners’ of US election


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.